These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 24773680

  • 1. New treatment for old disease: management of resistant hypertension by percutaneous renal sympathetic denervation.
    Kanai T, Krum H.
    Rev Esp Cardiol (Engl Ed); 2013 Sep; 66(9):734-40. PubMed ID: 24773680
    [Abstract] [Full Text] [Related]

  • 2. Renal sympathetic nerve ablation for treatment-resistant hypertension.
    Krum H, Schlaich M, Sobotka P.
    Br J Clin Pharmacol; 2013 Oct; 76(4):495-503. PubMed ID: 23819768
    [Abstract] [Full Text] [Related]

  • 3. Effect of renal nerve denervation for resistant hypertension in Thai patients: a report of the first cases series in Thailand.
    Wongpraparut N, Tresukosol D, Roubsantisuk W, Buranakitjaroen P, Chotivoraniyakul C, Pongakasira R.
    J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S155-61. PubMed ID: 24772593
    [Abstract] [Full Text] [Related]

  • 4. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea.
    Witkowski A, Prejbisz A, Florczak E, Kądziela J, Śliwiński P, Bieleń P, Michałowska I, Kabat M, Warchoł E, Januszewicz M, Narkiewicz K, Somers VK, Sobotka PA, Januszewicz A.
    Hypertension; 2011 Oct; 58(4):559-65. PubMed ID: 21844482
    [Abstract] [Full Text] [Related]

  • 5. [Renal denervation a treatment for resistant hypertension: a French experience].
    Benamer H, Mylotte D, Garcia-Alonso C, Unterseeh T, Garot P, Louvard Y, Lefevre T, Morice MC, ICV-GVM la Roseraie.
    Ann Cardiol Angeiol (Paris); 2013 Dec; 62(6):384-91. PubMed ID: 24182849
    [Abstract] [Full Text] [Related]

  • 6. Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension.
    Hering D, Marusic P, Walton AS, Lambert EA, Krum H, Narkiewicz K, Lambert GW, Esler MD, Schlaich MP.
    Hypertension; 2014 Jul; 64(1):118-24. PubMed ID: 24732891
    [Abstract] [Full Text] [Related]

  • 7. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
    Prochnau D, Lucas N, Kuehnert H, Figulla HR, Surber R.
    EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556
    [Abstract] [Full Text] [Related]

  • 8. [Renal artery denervation for treating refractory hypertension].
    Benamer H, Louvard Y, Garot P, Unterseeh T, Hovasse T, Lefèvre T, Chevalier B, Morice MC.
    Ann Cardiol Angeiol (Paris); 2011 Dec; 60(6):354-60. PubMed ID: 22040858
    [Abstract] [Full Text] [Related]

  • 9. The effect of percutaneous renal denervation on muscle sympathetic nerve activity in hypertensive patients.
    Vink EE, Verloop WL, Siddiqi L, van Schelven LJ, Liam Oey P, Blankestijn PJ.
    Int J Cardiol; 2014 Sep; 176(1):8-12. PubMed ID: 25027168
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Unilateral catheter-based renal sympathetic denervation in resistant arterial hypertension shows no blood pressure-lowering effect.
    Václavík J, Táborský M, Richter D.
    Clin Exp Hypertens; 2013 Sep; 35(3):192-4. PubMed ID: 22891761
    [Abstract] [Full Text] [Related]

  • 13. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months.
    Symplicity HTN-1 InvestigatorsCentre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University/Alfred Hospital, Melbourne, Victoria 3004, Australia. henry.krum@med.monash.edu.au.
    Hypertension; 2011 May; 57(5):911-7. PubMed ID: 21403086
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease.
    Schlaich MP, Bart B, Hering D, Walton A, Marusic P, Mahfoud F, Böhm M, Lambert EA, Krum H, Sobotka PA, Schmieder RE, Ika-Sari C, Eikelis N, Straznicky N, Lambert GW, Esler MD.
    Int J Cardiol; 2013 Oct 03; 168(3):2214-20. PubMed ID: 23453868
    [Abstract] [Full Text] [Related]

  • 18. [Percutaneous renal denervation as a new method of treatment of resistant arterial hypertension].
    Mach-Jamińska A, Sułowicz W.
    Przegl Lek; 2012 Oct 03; 69(11):1215-9. PubMed ID: 23646450
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.